Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04741438
Title Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype (RAR-Immune)
Acronym RAR-Immune
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de cancérologie Strasbourg Europe RECRUITING Strasbourg Bas-Rhin 67033 France Details
Centre Léon Bérard RECRUITING Lyon Rhône 69373 France Details
Hôpital Jean Minjoz RECRUITING Besançon 25030 France Details
Institut Bergonié RECRUITING Bordeaux France Details
Centre Georges François Leclerc RECRUITING Dijon France Details
Centre Oscar Lambret RECRUITING Lille France Details
Institut Paoli Calmettes NOT_YET_RECRUITING Marseille France Details
Centre Antoine Lacassagne RECRUITING Nice France Details
Hôpital Cochin NOT_YET_RECRUITING Paris France Details
CHU de Poitiers NOT_YET_RECRUITING Poitiers France Details
Centre Eugène Marquis RECRUITING Rennes France Details
Institut Claudius Regaud - IUCT Oncopole RECRUITING Toulouse France Details
Institut Gustave Roussy RECRUITING Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field